新藤黄酸纳米脂质体的构建与抗肝癌性能评价OA
Construction of Gambogenic Acid Nanoliposomes and Evaluation of Their Anti-hepatocellular Carcinoma Activity
目的:制备载新藤黄酸(GNA)的脂质体(GNA@Lip)并探讨 GNA@Lip 的体外抗肝癌活性机制.方法:⑴以外观形态、粒径分布、Zeta 电位、包封率、载药量及体外药物释放作为主要评价内容,对 GNA@Lip 进行表征;⑵通过增殖和凋亡实验考察 GNA@Lip 对肝癌细胞的生长抑制和凋亡诱导活性;⑶通过细胞跨膜实验考察 GNA@Lip的抗细胞侵袭能力;⑷检测 GNA@Lip 对肝癌细胞的线粒体膜电位、细胞内活性氧(ROS)累积的影响.结果:⑴TEM 形态观察显示 GNA@Lip 呈球形,其平均粒径和 Zeta 电位分别为(103.4±1.14)nm 和(-19.90±1.53)mV,GNA@Lip 新藤黄酸包封率达(91.45±1.26)%、载药量达(5.31±0.97)%,体外释放曲线表明 GNA@Lip 具有缓释效果;⑵GNA@Lip 对人正常肝细胞 THLE-2 具有良好的安全性,其对人肝癌细胞 HepG2、Huh7 及 Hep3B 的 IC50 值分别为3.62、4.65、5.07 μmol/L,分别是 GNA 溶液(IC50=7.94、8.59、8.58 μmol/L)的 0.46、0.54、0.59 倍,具有更明显的生长抑制效果;⑶与 GNA 溶液比较,GNA@Lip 对 HepG2 细胞的促凋亡和抑侵袭效果更显著;⑷GNA@Lip 能更有效地诱导线粒体膜电位下降和 ROS 累积,提示其诱导 HepG2 细胞凋亡可能涉及线粒体途径.结论:本研究成功制备了GNA@Lip,可以有效提高 GNA 的体外抗肝细胞癌药效,为提高 GNA 的抗肝癌药效提供了新型纳米给药方案.
Objective To prepare liposomes loaded with gambogenic acid(GNA@Lip)and explore the in vitro anti-hepato-cellular carcinoma mechanism of GNA@Lip.Methods ⑴GNA@Lip was characterized in terms of appearance,particle size distribution,zeta potential,encapsulation efficiency,drug loading,and in vitro drug release.⑵Proliferation and apop-tosis assays were performed to evaluate the growth-inhibitory and apoptosis-inducing activities of GNA@Lip against hepato-cellular carcinoma cells.⑶Transwell assays were conducted to assess the anti-invasion capability of GNA@Lip.⑷Its effects on mitochondrial membrane potential and reactive oxygen species(ROS)accumulation in hepatocellular carcinoma cells were examined.Results ⑴TEM morphology observation revealed that GNA@Lip exhibited a spherical shape,with an average particle size and zeta potential of(103.4±1.14)nm and(-19.90±1.53)mV,respectively.Its encapsulation effi-ciency reached(91.45±1.26)%,and the drug loading capacity was(5.31±0.97)%.The in vitro release curve indicated that GNA@Lip had a sustained-release effect.⑵GNA@Lip demonstrated high safety for human normal liver cells(THLE-2),with the IC50 values against HepG2,Huh7,and Hep3B being 3.62,4.65,and 5.07 μmol/L,respectively,which were 0.46,0.54,and 0.59 times those of gambogenic acid(GNA)solution(IC50=7.94,8.59,and 8.58 μmol/L),re-spectively,showing pronounced growth-inhibitory effects.⑶Compared with GNA solution,GNA@Lip exerted significantly stronger pro-apoptotic and anti-invasion effects on HepG2 cells.(4)GNA@Lip effectively induced mitochondrial mem-brane potential depolarization and intracellular ROS accumulation,suggesting that GNA@Lip-medicated apoptosis in HepG2 cells may involve the mitochondrial pathway.Conclusion This study successfully prepares GNA@Lip,which can enhance the in vitro anti-hepatocellular carcinoma activity of GNA,providing a novel nanodelivery strategy to improve the efficacy of GNA against hepatocellular carcinoma.
郭春燕;付卫争
皖北卫生职业学院药学系宿州市立医院,安徽 宿州 234000
新藤黄酸脂质体表征抗肿瘤肝癌
Gambogenic acidLiposomeCharacterizationAntitumorHepatocellular carcinoma
《湖北医药学院学报》 2026 (4)
486-492,7
安徽省高校自然科学重大研究项目(2024AH040232)
评论